Zeng et al. reported that a combination therapy of anti-PD-1 antibody and radiation increases long term survival by induction of CD8+ T cells infiltration and reduction of regulatory T cells in a glioma animal model, which has a low mutational burden [52]. Here, CD8A is linked to central nervous system cancer.